5 Proven Steps to Overcome Pricing Objections: A Step-by-Step Guide

The down economy has forced many advertisers to tighten up their purse strings. Here's a guide on how to overcome pricing objections.

Read

Are Pharma Brands Ready to Embrace Digital Advertising?

Are pharma brands ready to adopt full on digital advertising campaigns? Learn more about what's in store for this traditional industry segment.

Read

3 Ways to Sell Cross-Platform Advertising to Brands on a Budget

Cross-platform advertising should be a staple in the diet of nearly every advertiser. For a publisher engaging a prospective brand, the conversation should not simply center around whether or not the brand should engage in paid search, but rather how to integrate paid search with paid social, organic reach, podcast sponsorship, and more.

Read

Will Amazon Own the Programmatic Advertising Market?

How is amazon focusing on programmatic advertising, now that Amazon Advertising is gaining momentum?

Read

How Advertisers Are Spending on Digital Media Channels & How That Should Impact Your Strategy 

MediaRadar looked at a sampling of advertising on over 215 digital content companies like BBC News, ABC, USA Today, and more—with an audience of 257 million unique visitors. Here’s what the data shows, and what it means for your strategy.

Read

DTC Pharma Ad Trends: Overview and New Advertisers

Here’s what you need to know about how pharma companies—new and old—spent their ad dollars in 2021. 

Read

HIV/AIDS Prescription Drug Advertising: Looking Toward the Future

While prescription drug advertising has remained relatively stable, we see a different story when looking at recent digital ad spend for HIV/AIDS treatments.

Read

3 New Initiatives Taking Programmatic Advertising Higher

MediaRadar dives into three distinct developments that promise to take programmatic advertising to new heights.

Read

MediaRadar Predicts Snapchat’s Q1 Earnings Success

Todd Krizelman, CEO of MediaRadar, discusses Twitter’s recent success as well as predicted success for Facebook Inc. and Snap Inc.

Read